Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Quest/Unilab

This article was originally published in The Gray Sheet

Executive Summary

Diagnostic testing services firms complete merger Feb. 26 following an 11-month delay due to Federal Trade Commission concerns that the deal would lead to higher prices for clinical lab service customers in Northern California. A consent order with the agency requires that Quest divest assets worth $4.5 mil. to LabCorp - including leases for 46 patient services centers and four contracts with physician groups in Northern California. The $827 mil. cash and stock purchase of Unilab by Quest was first announced in April 2002 (1"The Gray Sheet" April 8, 2002, p. 19)...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT017980

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel